E. G. Hahn

5.3k total citations
132 papers, 4.0k citations indexed

About

E. G. Hahn is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, E. G. Hahn has authored 132 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Surgery, 32 papers in Pulmonary and Respiratory Medicine and 30 papers in Oncology. Recurrent topics in E. G. Hahn's work include Gastric Cancer Management and Outcomes (17 papers), Colorectal Cancer Treatments and Studies (15 papers) and Hepatocellular Carcinoma Treatment and Prognosis (13 papers). E. G. Hahn is often cited by papers focused on Gastric Cancer Management and Outcomes (17 papers), Colorectal Cancer Treatments and Studies (15 papers) and Hepatocellular Carcinoma Treatment and Prognosis (13 papers). E. G. Hahn collaborates with scholars based in Germany, Poland and United States. E. G. Hahn's co-authors include Joachim H. Ficker, Detlef Schuppan, Martin Raithel, H. T. Schneider, J Hochberger, Gerald Wiest, Ell C, Harald Dormann, J Maiß and Kay Brune and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Gut.

In The Last Decade

E. G. Hahn

122 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. G. Hahn Germany 37 1.3k 1.1k 811 743 546 132 4.0k
U Haglund Sweden 39 3.0k 2.2× 1.9k 1.8× 1.1k 1.4× 605 0.8× 112 0.2× 198 6.2k
Kazuma Fujimoto Japan 42 3.3k 2.5× 2.0k 1.9× 922 1.1× 662 0.9× 200 0.4× 186 6.7k
Paul A.M. van Leeuwen Netherlands 48 1.5k 1.1× 960 0.9× 1.8k 2.3× 2.4k 3.2× 189 0.3× 194 7.1k
Giuseppe Palasciano Italy 39 2.2k 1.7× 1.1k 1.0× 1.0k 1.3× 669 0.9× 78 0.1× 178 5.6k
Paul D. Berk United States 42 2.1k 1.5× 508 0.5× 684 0.8× 1.3k 1.8× 225 0.4× 123 6.2k
John J. Herbst United States 38 1.4k 1.1× 932 0.9× 382 0.5× 439 0.6× 227 0.4× 104 4.9k
Pius Hildebrand Switzerland 29 1.1k 0.8× 250 0.2× 361 0.4× 560 0.8× 455 0.8× 59 3.3k
Vito Guerra Italy 36 787 0.6× 542 0.5× 610 0.8× 601 0.8× 53 0.1× 158 4.3k
Thomas Sudhop Germany 30 1.7k 1.3× 157 0.1× 478 0.6× 362 0.5× 191 0.3× 61 3.3k
Carlo Sabbà Italy 46 1.7k 1.2× 1.3k 1.2× 537 0.7× 846 1.1× 53 0.1× 211 6.7k

Countries citing papers authored by E. G. Hahn

Since Specialization
Citations

This map shows the geographic impact of E. G. Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. G. Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. G. Hahn more than expected).

Fields of papers citing papers by E. G. Hahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. G. Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. G. Hahn. The network helps show where E. G. Hahn may publish in the future.

Co-authorship network of co-authors of E. G. Hahn

This figure shows the co-authorship network connecting the top 25 collaborators of E. G. Hahn. A scholar is included among the top collaborators of E. G. Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. G. Hahn. E. G. Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wollenberg, Lance, E. G. Hahn, Jason H. Williams, & Kevin Litwiler. (2023). A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C] encorafenib in healthy male subjects. Pharmacology Research & Perspectives. 11(5). e01140–e01140. 5 indexed citations
2.
Hahn, E. G., et al.. (2008). Metabolische Besonderheiten bei Patienten mit Multipler Symmetrischer Lipomatose. DMW - Deutsche Medizinische Wochenschrift. 133(45). 2323–2327. 1 indexed citations
3.
4.
Raithel, Martin, Sandra Winterkamp, Michael Weidenhiller, S. Müller, & E. G. Hahn. (2006). Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis. International Journal of Colorectal Disease. 22(7). 833–839. 10 indexed citations
5.
Schwab, Dieter, et al.. (2005). Biliary secretion of moxifloxacin in obstructive cholangitis and the non‐obstructed biliary tract. Alimentary Pharmacology & Therapeutics. 22(5). 417–422. 16 indexed citations
6.
Frieser, M, Anna L. Peters, T. Bernatik, et al.. (2005). Radiofrequency Ablation Using Perfused Needle Electrodes – Study of Intermittent and Continuous Triple Needle Application ex vivo. European Surgical Research. 37(5). 312–316. 6 indexed citations
7.
Frieser, M, et al.. (2004). Radiofrequency Ablation of Liver Tumors: How to Enlarge the Necrotic Zones?. European Surgical Research. 36(6). 357–361. 10 indexed citations
8.
Dormann, Harald, Manfred Criegee‐Rieck, Antje Neubert, et al.. (2004). Implementation of a computer‐assisted monitoring system for the detection of adverse drug reactions in gastroenterology. Alimentary Pharmacology & Therapeutics. 19(3). 303–309. 30 indexed citations
9.
Wein, A., Peter Martus, Christian U. Riedel, et al.. (2003). Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy. British Journal of Cancer. 88(8). 1248–1250. 18 indexed citations
10.
Winterkamp, Sandra, et al.. (2003). Standardised evaluation of urinary excretion of N-tele-methylhistamine in different periods of age in a healthy population. Inflammation Research. 52(0). s57–s58. 6 indexed citations
11.
Wehler, Markus, Udo Reulbach, B. Fischer, et al.. (2003). Health‐related quality of life in chronic pancreatitis: a psychometric assessment. Scandinavian Journal of Gastroenterology. 38(10). 1083–1089. 54 indexed citations
12.
Kuefner, Michael A., et al.. (2002). Total histamine degradation capacity (THDC) as an important biological marker of histamine metabolism in human colonic mucosa. Inflammation Research. 51(S1). 87–88. 7 indexed citations
13.
Winterkamp, Sandra, Michael Weidenhiller, Jennifer Stolper, et al.. (2002). Urinary Excretion of N-Methylhistamine as a Marker of Disease Activity in Inflammatory Bowel Disease. The American Journal of Gastroenterology. 97(12). 3071–3077. 83 indexed citations
14.
Fischer, B., et al.. (2001). Faecal Elastase-1: Lyophilization of Stool Samples Prevents False Low Results in Diarrhoea. Scandinavian Journal of Gastroenterology. 36(7). 771–774. 52 indexed citations
15.
Konturek, Stanisław J., et al.. (2001). Implication of gastrin in cyclooxygenase-2 expression in Helicobacter pylori infected gastric ulceration. Prostaglandins & Other Lipid Mediators. 66(1). 39–51. 22 indexed citations
16.
Wiest, Gerald, Florian Fuchs, Simin Pour Schahin, et al.. (2001). Reproducibility of a Standardized Titration Procedure for the Initiation of Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnoea. Respiration. 68(2). 145–150. 16 indexed citations
17.
Ell, Christian, Liebwin Goßner, Andrea May, et al.. (1998). Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut. 43(3). 345–349. 62 indexed citations
18.
19.
Konturek, P C, et al.. (1996). Expression of Epidermal Growth Factor and Transforming Growth Factor-α after Exposure of Rat Gastric Mucosa to Stress. Scandinavian Journal of Gastroenterology. 31(3). 209–216. 33 indexed citations
20.
Brzozowski, Tomasz, Peter C. Konturek, S J Konturek, et al.. (1995). Gastric adaptation to injury by repeated doses of aspirin strengthens mucosal defence against subsequent exposure to various strong irritants in rats.. Gut. 37(6). 749–757. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U Haglund Breakdown of academic impact, for papers by Kazuma Fujimoto Breakdown of academic impact, for papers by Paul A.M. van Leeuwen Breakdown of academic impact, for papers by Giuseppe Palasciano Breakdown of academic impact, for papers by Paul D. Berk Breakdown of academic impact, for papers by John J. Herbst Breakdown of academic impact, for papers by Pius Hildebrand Breakdown of academic impact, for papers by Vito Guerra Breakdown of academic impact, for papers by Thomas Sudhop Breakdown of academic impact, for papers by Carlo Sabbà
Rankless by CCL
2026